Albert Leon Charles Calmette (1863-1933) and the Antituberculous BCG Vaccination
- 1 June 2001
- journal article
- other
- Published by Project MUSE in Perspectives in Biology and Medicine
- Vol. 44 (3) , 379-389
- https://doi.org/10.1353/pbm.2001.0044
Abstract
Albert Leon Charles Calmette was the first person to develop an anti-venom serum. His work revolutionized the treatment of snakebite in men and domestic animals. He is also well known for his development of the Bacillus Calmette-Guerin (BCG) vaccine for the prevention of tuberculosis. This article reviews the life experiences of this pioneer bioscientist, the current status of BCG in preventing tuberculosis, and the potential of BCG in immunotherapy for cancer.Keywords
This publication has 10 references indexed in Scilit:
- Tuberculosis II: the failure of the BCG vaccineMedical Hypotheses, 1999
- Mycobacterial infections: Are the observed enigmas and paradoxes explained by immunosuppression and immunodeficiency?Medical Hypotheses, 1996
- Sir Joseph Fayrer MD FRS (1824–1907) Indian Medical Service: Snakebite and mortality in British IndiaToxicon, 1996
- BCG priming enhances endotoxin-induced acute lung injury independent of neutrophils.American Journal of Respiratory and Critical Care Medicine, 1995
- Humoral immune response in infants after BCG vaccinationTubercle and Lung Disease, 1995
- Bacillus calmette—Guérin treatment of existing papillary bladder cancer and carcinoma in situ of the bladder. Four-year resultsCancer, 1995
- Positive Urinary Cytology Following a Complete Response to Intravesical Bacillus Calmette-Guerin Therapy: Pattern of RecurrenceJournal of Urology, 1994
- Immunotherapy of guinea pig cancer with bcgCancer, 1974
- Accelerated Rejection of Male Skin Isografts by Female G57BL Mice Infected with Bacillus Calmette-Guerin (B.C.G.).Experimental Biology and Medicine, 1962
- The Treatment of Animals Poisoned with Snake Venom by the Injection of Antivenomous SerumBMJ, 1896